Skip to Main Content
Important Announcement: The NEOMED Library is migrating to a new library system in conjunction with our
Hospital Affiliate and
OhioLINK Library partners. There will be some interruptions to the circulation of library materials beginning on Friday, May 23, 2025. Please review the
NEOMED Library System Upgrade guide for more information.
Breast cancer
- Comparing trastuzumab to bevacizumab for the treatment of breast cancer
- Zoledronate versus ibandronate for the treatment of breast cancer
- Anastrozole versus tamoxifen for the treatment of breast cancer
- Letrozole versus tamoxifen for treating breast cancer
- Letrozole versus anastrozole for treating breast cancer
Accelerated approval for new cancer drugs
- Vemurafenib (formerly PLX4032) for treating metastatic melanoma. Find one randomized control trial comparing this drug to another drug. For your second article, find an article testing PLX4032 on cancer cell lines. Choose a review article of your choice.
- Crizotinib for treating non-small cell lung cancer. See H. McEwen about the choosing your articles.
Melanoma
- Ipilimumab and sargramostim compared to ipilimumab for treating metastatic melanoma
- Nivolumab vs ipilimumab for treating melanoma
- Nivolumab vs Ipilimumab vs Nivolumab and Ipilimumab for treating advanced melanoma
- Vemurafenib vs dabrafenib vs trametinib for treating metastatic melanoma